Abstract
The major risk factors for hepatocellular carcinomas (HCC) in high incidence areas include infection with hepatitis B and C viruses (HBV, HCV) and exposure to aflatoxin. Genetic alterations in 24 liver resection specimens from Shanghai and Qidong were studied. Hepatitis B virus was integrated in all patient samples, and a null phenotype for the GSTM1 enzyme was present in 63% of patients. Alteration of p53 was present in 95% (23/24) of cases: mutations of the p53 gene in 12 HCC, p53 overexpression in 13 and loss of heterozygosity (LOH) of chromosome 17p in 17. All seven HCCs with a p53 mutation from Qidong and three of five from Shanghai had the aflatoxin-associated point mutation with a G to T transversion at codon 249, position 3. No HCC had microsatellite instability. LOH of chromosome 4q, 1p, 16q and 13q was present in 50%, 46%, 42% and 38%, respectively, and 4q was preferentially lost in HCCs containing a p53 mutation: LOH of 4q was present in 75% (9/12) of HCC with, but only 25% (3/12) of HCC without, a p53 gene mutation (P = 0.01). These data indicate a possible interaction between p53 gene mutation and 4q loss in the pathogenesis of HCC.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aguilar, F., Hussain, S. P. & Cerutti, P. (1993) Aflatoxin B1 induces the transversion of G-T in codon 249 of the tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90: 8586–8590.
Bankfalvi, A., Navabi, H., Bier, B., Bocker, W., Jasani, B. & Schmid, K. W. (1994) Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174: 223–228.
Becker, S. A., Zhou, Y-Z & Slagle, B. L. (1996) Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 56: 5092–5097.
Boige, V., Laurent-Puig, P., Fouchet, P., Flejou, J. F., Monges, G., Bedossa, P., Bioulac-Sage, P., Capron, F., Schmitz, A., Olschwang, S. & Thomas, G. (1997) Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 57: 1986–1990.
Bourdon, J-C, D’Errico, A., Paterlini, P., Grigioni, W., May, E. & Debuire, B. (1995) p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108: 1176–1182.
Bressac, B., Kew, M., Wands, J. & Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond) 350: 429–431.
Brockmoller, J., Kerb, R., Drakoulis, N., Nitz, M. & Roots, I. (1993) Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and control. Cancer Res 53: 1004–1011.
Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V., Brechot, C., Redeker, A. & Govindarajah, S. (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852–8856.
Chen, H-L, Chen, Y-C & Chen, D-S (1996) Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet 86: 102–106.
Comstock, K. E., Sanderson, B. J. S., Claflin, G. & Henner, W. D. (1990) GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res 18: 3670
Coursaget, P., Depril, N., Chabaud, M., Nandi, R., Mayelo, V., LeCann, P. & Yvonnet, B. (1993) High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 67: 1395–1397.
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C. & Jirtle, R. L. (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11: 447–449.
Devilee, P., Vliet, M., Bardoel, A., Kievits, T., Kuipers-Dijkshoon, N., Pearson, P. L. & Cornelisse, C. J. (1991) Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51: 1020–1025.
Dohner, H., Bloomfield, C. D., Frizzera, G., Frestedt, J. & Arthur, D. C. (1992) Recurring chromosome abnormalities in Hodgkin’s disease. Genes Chromosom Cancer 5: 392–398.
Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., Housman, D. E. & Kefford, R. F. (1989) Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 88: 4614–4618.
Dumenco, L., Oguey, D., Wu, J., Messier, N. & Fausto, N. (1995) Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology 22: 1279–1288.
Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M. & Nakamura, Y. (1992) Frequent loss of heterozygosity for loci on chromosome 8 p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368–5372.
Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K. & Nakamura, Y. (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89–93.
Gleeson, C. M., Sloan, J. M., McGuigan, J. A., Ritchie, A. J., Weber, J. L. & Russell, S. H. E. (1997) Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer 76: 1455–1465.
Greenblatt, M. S., Feitelson, M. A., Zhu, M., Bennett, W. P., Welsh, J. A., Borkowski, A. & Harris, C. C. (1997) Integrity of p53 in hepatitis B X antigen-positive and -negative hepatocellular carcinoma. Cancer Res 57: 426–432.
Groopman, J. D., Wang, J-S & Scholl, P. (1996) Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can J Physiol Pharmacol 74: 203–209.
Hammoud, Z. T., Kaleem, Z., Cooper, J. D., Sundaresan, S., Patterson, G. A. & Goodfellow, P. J. (1996) Alleotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequence on the long arm of chromosome 4. Cancer Res 56: 4499–4502.
Hampton, G. M., Larson, A. A., Baergen, R. N., Sommers, R. L., Kern, S. & Cavenee, W. K. (1996) Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93: 6704–6709.
Hayashi, H., Sugio, K., Matsumata, T., Adachi, E., Takenaka, K. & Sugimachi, K. (1995) The clinical significance of p53 gene mutation in hepatocelluar carcinomas from Japan. Hepatology 22: 1702–1707.
Henkler, F., Waseem, N., Golding, M. H. C., Alison, M. R. & Koshy, R. (1995) Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus related human hepatocellular carcinoma. Cancer Res 55: 6084–6091.
Hsu, H-C, Peng, S-Y, Lai, P-L, Sheu, J-C, Chen, D-S, Lin, L-I, Slagle, B. L. & Butel, J. S. (1994) Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. Cancer 73: 42–47.
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J. & Harris, C. C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond) 350: 427–428.
Hsu, I. C., Tokiwa, T., Bennett, W., Metcalf, R. A., Welsh, J. A., Sun, T. & Harris, C. C. (1993) p53 gene mutation and integrated hepatitis B viral DNA sequences in human cancer cell lines. Carcinogenesis (Lond) 14: 987–992.
Inazawa, J., Ariyama, T., Abe, T., Druck, T., Ohta, M., Huebner, K., Yanagisawa, J., Reed, J. C. & Sato, T. (1996) PTPN13, a Fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3. Genomics 31: 240–242.
Katagiri, T., Nakamura, Y. & Miki, Y. (1996) Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res 56: 4575–4577.
Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. & Manns, M. (1995) Low incidence of p53 mutations in European hepatocellular carcinoma with heterogeneous mutation as a rare event. J Hepatol 23: 412–419.
Kuroki, T., Fujiwara, Y., Nakamori, S., Imaoka, S., Kanematsu, T. & Nakamura, Y. (1995a) Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13 q. Br J Cancer 72: 383–385.
Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., Kanematsu, T. & Nakamura, Y. (1995b) Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosom Cancer 13: 163–167.
Leister, I., Weith, A., Bruderlein, S., Cziepluch, C., Kangwanpong, D., Schlag, P. & Schwab, M. (1990) Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res 50: 7232–7235.
Leon, M. & Kew, M. C. (1996) Loss of heterozygosity in chromosome 4q12–q13 in hepatocellular carcinoma in Southern African blacks. Anticancer Res 16: 349–352.
Mace, K., Aguilar, F., Wang, J-S, Vautravers, P., Gomez-Lechon, M., Gonzalez, F. J., Groopman, J., Harris, C. C. & Pfeifer, A. M. A. (1991) Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis (Lond) 7: 1291–1297.
Marchio, A., Meddeb, M., Pineau, P., Danglot, G., Tiollais, P., Bernheim, A. & Dejean, A. (1997) Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosom Cancer 18: 59–65.
McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X-L, Baffoe-Bonnie, A., Ofori-Adjei, D., Chen, G-C, London, W. T., Shen, F-M & Buetow, K. H. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 . Proc Natl Acad Sci USA 92: 2384–2387.
Mitra, A. B., Murty, VVVS, Li, R. G., Pratap, M., Luthra, U. K. & Chaganti, R. S. K. (1994) Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481–4487.
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A. & Dejean, A. (1997) Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927–2933.
Nasarek, A., Werner, M., Nolte, M., Klempnauer, J. & Georgii, A. (1995) Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study. Virchows Arch 427: 373–378.
Nasir, J., Theilmann, J. L., Chopra, V., Jones, A. M., Walker, D., Rasper, D. M., Vaillancourt, J. P., Hewitt, J. E., Nicholson, D. W. & Hayden, M. R. (1997) Localization of the cell death genes CPP32 and Mch-2 to human chromosome 4q. Mammalian Genome 8: 56–59.
Ning, Y., Weber, J. L., Killary, A. M., Ledbetter, D. H., Smith, J. R. & Pereira-Smith, O. M. (1991) Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88: 5635–5639.
Nose, H., Imazeki, F., Ohto, M. & Omata, M. (1993) p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 72: 355–360.
Ozturk, M., Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., Takahashi, H., von Weizsäcker, F., Galun, E., Siddhartha, K., Carr, B. I., Schröder, C. H., Erken, E., Varinli, S., Rustgi, V. K., Prat, J., Toda, G., Koch, H. K., Liang, X. H., Tang, Z-Y, Shouval, D., Lee, H-S, Vyas, G. N. & Sarosi, I. (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338: 1356–1359
Pershouse, M. A., El-Naggar, A. K., Hurr, K., Lin, H., Yung, W. K. A. & Steck, P. A. (1997) Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 14: 369–373.
Polascik, T. J., Cairns, P., Chang, W. Y. H., Schoenberg, M. P. & Sidransky, D. (1995) Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 55: 5396–5399.
Ponchel, F., Puisieux, A., Tabone, E., Michot, J. P., Froschl, G., Morel, A. P., Frebourg, T., Fontaniere, B., Oberhammer, F. & Ozturk, M. (1994) Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis. Cancer Res 54: 2064–2068.
Qian, G-S, Ross, R. K., Yu, M. C., Yuan, J-M, Gao, Y-T, Henderson, B. E., Wogan, G. N. & Groopman, J. D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 3: 3–10.
Rashid, A. & Hamilton, S. R. (1997) Genetic alterations in sporadic and Crohn’s-associated adenocarcinomas of the small intestine. Gastroenterology 113: 127–135.
Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J. & Kern, S. E. (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54: 3025–3033.
Shi, C. Y., Phang, T. W., Lin, Y., Wee, A., Li, B., Lee, H. P. & Ong, C. N. (1995) Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br J Cancer 72: 146–149.
Simon, D., Knowles, B. B. & Weith, A. (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765–770.
Slagle, B. L., Zhou, Y-Z, Birchmeier, W. & Scorsone, K. A. (1993) Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 18: 757–762.
Takahashi, K., Kudo, J., Ishibashi, H., Hirata, Y. & Niho, Y. (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 17: 794–799.
Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T. & Hirohashi, S. (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791–6794.
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A. & Jay, G. (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet 9: 41–47.
Urano, Y., Watanabe, K., Lin, C. C., Hino, O. & Tamaoki, T. (1991) Interstitial chromosomal deletion within 4q11–q13 in a human hepatoma cell line. Cancer Res 51: 1460–1464.
Verhaegh, GWCT, Jongmans, W., Jaspers, N. G. J., Natarajan, A. T., Oshimura, M., Lohman, P. H. M. & Zdzienicka, M. Z. (1995) A gene that regulates DNA replication in response to DNA damage is located on human chromosome 4q. Am J Hum Genet 57: 1095–1103.
Walker, G. J., Hayward, N. K., Falvey, S. & Cooksley, W. G. E. (1991) Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 51: 4367–4370.
Wang, H. P. & Rogler, C. E. (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48: 72–78.
Weith, A., Martinsson, T., Cziepluch, C., Bruderlein, S., Amler, L. C., Berthold, F. & Schwab, M. (1989) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosom Cancer 1: 159–166.
Yeh, S-H, Chen, P-J, Chen, H-L, Lai, M-Y, Wang, C-C & Chen, D-S (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188–4192.
Yeh, S-H, Chen, P-J, Lai, M-Y & Chen, D-S (1996) Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated α-fetoprotein production. Gastroenterology 110: 184–192.
Yu, M-W & Chen, C-J (1994) Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 17: 71–91.
Yumoto, Y., Hanafusa, T., Hada, H., Morita, T., Ooguchi, S., Shinji, N., Mitani, T., Hamaya, K., Koide, N. & Tsuji, T. (1995) Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 10: 179–185.
Zhang, W., Hirohashi, S., Tsuda, H., Shimosato, Y., Yokota, J., Terada, M. & Sugimura, T. (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81: 108–111.
Zhang, X., Xu, H-J, Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S-X, Benedict, W. F. & Sekiya, T. (1994) Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54: 4177–4182.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Rashid, A., Wang, JS., Qian, GS. et al. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer 80, 59–66 (1999). https://doi.org/10.1038/sj.bjc.6690321
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690321
Keywords
This article is cited by
-
Mode of action-based risk assessment of genotoxic carcinogens
Archives of Toxicology (2020)
-
Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice
Archives of Toxicology (2019)
-
Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes
Scientific Reports (2017)
-
The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey
Journal of Gastrointestinal Cancer (2010)
-
Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE
BMC Medical Genomics (2009)